A detailed history of City State Bank transactions in Moderna, Inc. stock. As of the latest transaction made, City State Bank holds 50 shares of MRNA stock, worth $1,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$1,842
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$85.37 - $115.44 $6,402 - $8,658
-75 Reduced 60.0%
50 $5,000
Q3 2023

Oct 16, 2023

BUY
$96.41 - $126.61 $4,820 - $6,330
50 Added 66.67%
125 $13,000
Q1 2023

Apr 10, 2023

SELL
$135.66 - $197.02 $10,174 - $14,776
-75 Reduced 50.0%
75 $12,000
Q4 2021

Mar 11, 2022

BUY
$225.82 - $368.51 $33,873 - $55,276
150 New
150 $20,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track City State Bank Portfolio

Follow City State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.